TriSalus Life Sciences, Inc. Common Stock
Symbol: TLSI (NASDAQ)
0.00
▼ (-100.00%) -4.680
Company Description:
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $4.68
- Yesterday High: $4.8
- Yesterday Low: $4.59
- Yesterday Volume: 75.03K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: TriSalus Life Sciences, Inc. Common Stock
- Website: https://www.trisaluslifesci.com
- Listed Date: 2023-08-11
- Location: WESTMINSTER, CO
- Market Status: Active
- CIK Number: 0001826667
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $235.87M
- Round Lot: 100
- Outstanding Shares: 49.87M
- Asset Type: CS
RECENT FILINGS FOR TLSI
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-29 | 4 | View |
| 2025-08-29 | 8-K | View |
| 2025-08-18 | SCHEDULE 13G | View |
| 2025-08-15 | 4 | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-08-04 | SCHEDULE 13D/A | View |
| 2025-08-01 | SCHEDULE 13D/A | View |
| 2025-07-25 | SC TO-I/A | View |
| 2025-07-24 | 8-K | View |
| 2025-07-22 | EFFECT | View |
| 2025-07-15 | SC TO-I/A | View |
| 2025-07-11 | S-4/A | View |
| 2025-07-10 | 3 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
Latest News on TLSI